BTAIQ: BioXcel Therapeutics, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | Fell below 5% | Armistice Capital, LLC | 4.99% | SEC |
Institutional ownership (Q2 2026)
47 institutions reported holding $8.66M of BioXcel Therapeutics, Inc. on Form 13F (40 the quarter before). 10 opened a new position and 3 sold out. Shares held by institutions: +14%.
| Largest holders | Shares | Value |
|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 2,114,710 | $2.98M |
| OAKTREE CAPITAL MANAGEMENT LP | 1,380,248 | $1.95M |
| VANGUARD CAPITAL MANAGEMENT LLC | 919,545 | $1.30M |
| Oaktree Fund Advisors, LLC | 245,585 | $346K |
| GEODE CAPITAL MANAGEMENT, LLC | 242,251 | $342K |
| BlackRock, Inc. | 179,433 | $253K |
| UBS Group AG | 158,065 | $223K |
| CITADEL ADVISORS LLC | 149,220 | $210K |
| VANGUARD FIDUCIARY TRUST CO | 136,937 | $193K |
| STATE STREET CORP | 92,118 | $130K |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.